IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Stock Information for Magal Security Systems Ltd.

Loading

Please wait while we load your information from QuoteMedia.